Serum Uric Acid Is Associated with Metabolic Syndrome and Insulin Resistance among Health Personnel from Peru

Table 1

Prevalence ratio for MetS according to SUA tertiles by overall population and sex.

	Serum uric acid (tertiles)			Serum uric acid (mg/dL)
	T1	T2	T3
	PR	PR (95% CI)	PR (95% CI)	PR (95% CI)
Men
Metabolic syndrome
Model 1^a	1	2.19 (1.01–4.72)	2.11 (0.98–4.57)	1.40 (0.98–2.00)
Model 2^b	1	2.36 (1.12–4.95)	1.73 (0.80–3.75)	1.29 (0.91–1.83)
Model 3^c	1	1.79 (0.98–3.23)	1.31 (0.71–2.42)	1.23 (0.93–1.64)
Women
Metabolic syndrome
Model 1^a	1	1.62 (0.94–2.80)	2.72 (1.69–4.38)	1.49 (1.26–1.76)
Model 2^b	1	1.46 (0.85–2.50)	2.43 (1.50–3.93)	1.45 (1.23–1.72)
Model 3^c	1	1.16 (0.68–1.96)	1.71 (1.07–2.74)	1.24 (1.01–1.52)

T1: low tertile; T2: middle tertile; T3: high tertile; CI: confidence interval; PR: prevalence ratio;  < 0.05;  < 0.01; ^anonadjusted; ^badjusted for age; ^cadjusted for age, BMI, diabetes family history, physical activity, feeding habits, alcohol consumption, and smoking. Prevalence ratios and confidence intervals were calculated with Poisson regression with robust variance.